Category Medicine and Healthcare
Press Release
Interactive Strength Inc. (NASDAQ: TRNR) Secures New $200k+ Wattbike Order From Fitness First in Germany
Driven by rollout of the next-generation Wattbike AIR-PRO across Germany's Fitness First's premium Black Label facilities Major order follows April's $1M+ order from Woodway for the US market Read More
Press Release
CLS Health Strengthens Its Community Care Network in Southeast Houston and Pasadena
More top doctors joined the region's leading physician-owned healthcare group in 2025, increasing patients' access to primary care and medical specialties including family medicine, cardiology, vascular surgery, pain management, rheumatology, and podiatry. Read More
Press Release
FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Conditional approval extended through December 2026 for the treatment of CID in dogs CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA's June deadline - 51 dogs enrolled to date; ~49 more expected Read More
Press Release
Campo Indictment Exposes DEA Rotted From Within - While Medical Cannabis Research and Patients Wait Seven Years
A Federal Indictment That Reads Like a Narco-State Thriller DEA corruption reaches new levels with the Campo indictment, even as the agency continues its unprecedented seven-year delay of MMJ International Holding's FDA sanctioned clinical trial program. for Huntington's Disease. President Trump and Terry Cole cleaning out the DEA corruption. Read More
Press Release
Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025
100% of patients in Cohorts 1-3 remain free of cytokine release syndrome CRIS-7-derived CD3 design underpins a controlled T-cell response, supporting the differentiated safety profile, combinability with standard of care Read More
Press Release
Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders
Jaguar CEO Lisa Conte presenting December 10 from 3:25pm - 3:35pm Eastern at the Emerging Growth Conference to provide updates on near-term catalysts; Click here to register Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure due to microvillus inclusion disease (MVID), reducing the volume of the total parenteral support (PS) necessary for them to survive, though with associated toxicity; Groundbreaking PS reduction of up to 37%; No approved treatments exist for MVID Company completed meeting with FDA October 2, 2025 for advice on advancing its ongoing placebo-controlled trial of crofelemer in support of possible expedited approval pathway for crofelemer for treatment of MVID Read More
Press Release
Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network
Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy's cash price Proprietary EinsteinRx™ artificial intelligence pharmacy platform empowers the 6,500+ pharmacies in the Wellgistics Pharmacy Network to educate patients and providers on the advantages of Brenzavvy vs. Jardiance® and other SGLT-2 inhibitors Reduced out-of-pocket costs for patients, paired with a patient-education revenue opportunity for pharmacists, are designed to support broader market access to Brenzavvy and enhance the overall care experience Launch establishes a new model for next-generation reformulated drugs that offer patient-specific product advantages compared with entrenched market leaders Read More
Press Release
Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science
The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have access to controlled substances for legitimate medical use. Today, the evidence shows the opposite: DEA officials laundering cartel money, DEA lawyers defending unconstitutional judicial processes, DEA executives cycling into industry roles they once regulated and DEA policies obstructing legitimate FDA authorized medical research. Read More
Press Release
NEI Highlights Dr. Angela Fisher and Queer Safety Panel at "Celebrate & Connect" Grand Opening Wellness Event
"Queer Safety: Building Truly Affirming Systems for LGBTQ+ and Neurodivergent Lives" A Candid Conversation on Safety, Ethics, and Affirming Care for LGBTQ+ and Neurodivergent Communities Read More
Press Release
President Trump Fixing DEA Marijuana Policy: Defies Logic, Law, and Science, Says MMJ International Holdings
MMJ International Holdings Exposes the Impossible Federal Catch-22 Blocking FDA Regulated Cannabis Medicine. "This is an equation with no solution. To follow the rule is to commit a felony, and to follow the law is to violate the rule. This is the first paradox I've encountered that violates logic and the U.S. criminal code simultaneously." stated Duane Boise, CEO MMJ International Holdings. Read More
Press Release